Spectral Medical Inc.
EDT.TO
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -44.09% | -16.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -44.09% | -16.59% | |||
| Cost of Revenue | -43.07% | 22.21% | |||
| Gross Profit | -45.22% | -38.22% | |||
| SG&A Expenses | -22.15% | 5.87% | |||
| Depreciation & Amortization | 6.23% | 104.79% | |||
| Other Operating Expenses | 132.04% | -18.93% | |||
| Total Operating Expenses | -21.81% | 7.70% | |||
| Operating Income | 16.41% | -15.88% | |||
| Income Before Tax | 90.75% | -1,475.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 90.75% | -1,475.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 90.75% | -1,475.46% | |||
| EBIT | 16.41% | -15.88% | |||
| EBITDA | 16.41% | -15.50% | |||
| EPS Basic | 90.87% | -1,465.31% | |||
| Normalized Basic EPS | 107.57% | -1,561.29% | |||
| EPS Diluted | 90.87% | -1,465.31% | |||
| Normalized Diluted EPS | 107.57% | -1,561.29% | |||
| Average Basic Shares Outstanding | 1.67% | 0.72% | |||
| Average Diluted Shares Outstanding | 1.67% | 0.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||